Kiniksa Pharmaceuticals International (KNSA) Interest & Investment Income (2017 - 2022)
Kiniksa Pharmaceuticals International (KNSA) reported Interest & Investment Income of $322000.0 for Q3 2022, up 6340.0% on a YoY basis from $5000.0 in Q3 2021, and up 212.62% quarter-over-quarter from $103000.0 in Q2 2022.
Kiniksa Pharmaceuticals International (KNSA) Interest & Investment Income (2017 - 2022) Analysis & Trends
Kiniksa Pharmaceuticals International has reported Interest & Investment Income for 6 years, with the latest figure at $322000.0 in Q3 2022.
- For the quarter ending Q3 2022, Interest & Investment Income rose 6340.0% year-over-year to $322000.0; the trailing twelve-month figure through Sep 2022 stood at $536000.0 (up 972.0% YoY), and the FY2021 full-year result was $97000.0, down 91.45% from the prior year.
- Interest & Investment Income for Q3 2022 stood at $322000.0, up from $103000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.8 million in Q1 2019, with the low at $5000.0 in Q3 2021.
- Historically, Interest & Investment Income has averaged $655736.8 across 5 years, with a median of $305000.0 in 2018.
- Annual changes were most pronounced in 2021 — Interest & Investment Income tumbled 98.86% — and 2022, when it surged 6340.0%.
- Kiniksa Pharmaceuticals International's Interest & Investment Income stood at $1.7 million in 2018, then slumped by 34.57% to $1.1 million in 2019, then sank by 97.35% to $30000.0 in 2020, then soared by 156.67% to $77000.0 in 2021, then surged by 318.18% to $322000.0 in 2022.
- The last three Interest & Investment Income figures came in at $322000.0 (Q3 2022), $103000.0 (Q2 2022), and $34000.0 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Kiniksa Pharmaceuticals International | 3.79 Bn | 3.32 Bn | 193.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 322,000.00 |
| Jun 30, 2022 | 103,000.00 |
| Mar 31, 2022 | 34,000.00 |
| Dec 31, 2021 | 77,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 9,000.00 |
| Dec 31, 2020 | 30,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Jun 30, 2020 | 266,000.00 |
| Mar 31, 2020 | 789,000.00 |
| Dec 31, 2019 | 1.13 Mn |
| Sep 30, 2019 | 1.39 Mn |
| Jun 30, 2019 | 1.72 Mn |
| Mar 31, 2019 | 1.81 Mn |
| Dec 31, 2018 | 1.73 Mn |
| Sep 30, 2018 | 1.62 Mn |
| Jun 30, 2018 | 1.07 Mn |
| Mar 31, 2018 | 305,000.00 |
| Dec 31, 2017 | 133,000.00 |